- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06026384
Evaluation of Text or Animation-based Narrative and Non-narrative Interventions to Enhance Cancer Literacy: a Pilot Study (CLARO) (CLARO)
Development and Evaluation of Theory Guided Narrative and Non-narrative Interventions to Enhance Cancer Literacy and Cancer Prevention Beliefs in the Population: a Pilot Study
Study Overview
Status
Conditions
Detailed Description
CLARO aims to answer the question, how information materials should be designed to strengthen optimistic beliefs on cancer prevention and to indirectly facilitate the acquisition of cancer literacy.
Four different information materials were developed and will be tested in this pilot study (2x2-design: text or animation-based / narrative or non-narrative). Participants will take part in a 30- to 40-minute survey. As part of the study, they will be randomly assigned to one of the information materials, and asked to evaluate it in depth, both quantitatively and qualitatively. The interviews will be conducted individually and face to face.
Recruitment: Two research assistants will approach potential participants at a shopping center in Heidelberg, Germany, to invite them to participate in the study. Participants will receive a leaflet with further details and contact information. Those interested will be able to participate immediately at a designated room next to the center, provided by the National Cancer Prevention Center, where all interviews will take place, or schedule an appointment via email. As an incentive, participants will receive 30€ via bank transfer upon completing the interview.
Randomization Procedure: Simple randomization - a research assistant will use an Excel spreadsheet to generate random participant codes, which will then be integrated into LimeSurvey to ensure a closed survey environment. The list of codes will be password protected and not accessible to the two research assistants who will conduct the interviews. LimeSurvey will then assign individual codes to participants. Participant codes and allocation details will then be printed on paper and placed within sealed envelopes. Interviewers will then use these envelopes to select the corresponding intervention guide.
Semi-Structured Interview: Post-intervention, participants will take part in a semi-structured interview. With participant permission, all interviews will be audio-recorded on VLC media player. The interviews will be conducted by two research assistants with a background in psychology and previous training on the interview technique.
Transcription: The audio recordings will be transcribed verbatim by the two research assistants using the MAXQDA 2022 (VERBI Software, 2021) and will be reviewed by the principal investigators for accuracy. The interviews, original transcriptions, and data analysis will be in German. All quotes will be translated into English and back-translated by two independent members of the research team to ensure that the meaning will be preserved.
By using a mixed method approach the study will combine quantitative and qualitative methods addressing the following research questions:
Quantitative:
- What is the sample's socio-demographics? (e.g. age, gender, highest educational degree, current occupational status, and income)
- Has there already been personal contact with people with cancer (e.g. through own cancer or cancer in the family)?
- What is the level of engagement in health behaviours (smoking, healthy eating, exercise, BMI)?
- How strongly are Cancer Prevention Beliefs and Cancer Information Overload represented?
- How much do the participants like the material shown? (three questions on satisfaction with the material as well as possible counter-argumentation in order to exclude distortions due to social desirability)
- Can the people in the narrative conditions identify with the characters shown?
Qualitative:
- Do the participants like the materials?
- Is there something wrong with the quality of the materials? (e.g., quality of sound & images, presentation of animated figures, font size, readability...)
- Are the materials comprehensible?
- Is the amount of information appropriate? If not, is it too less or too much?
- Is the information given convincing?
- What are the most important insights gained from the materials? Do any of the information have novelty value?
- Are the given recommendations perceived as helpful?
- Are there ways to improve the materials?
- Might anyone feel excluded or offended by the information?
An inductive content analysis will be carried out to analyse the qualitative data obtained.
The results of the CLARO pilot study will help to improve the intervention materials that will be used for the subsequent main study.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mona Illmann, M. Sc.
- Phone Number: 06221 422370
- Email: mona.illmann@dkfz-heidelberg.de
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Between 18 and 70 years old
- Being able to speak and understand german
Exclusion Criteria:
- Not being able and willing to provide informed consent and complete questionnaires
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Non-Narrative Text
A short text (480 words) that deals with the preventability of cancer cases.
It shows that lifestyle factors such as smoking, unhealthy diet, obesity and physical inactivity are responsible for about 40% of cancer cases.
It also suggests ways to reduce the risk of cancer through behavioural changes in these areas.
A special focus is on nutrition and physical activity.
The text was developed on the basis of the Protection Motivation Theory.
|
Participants will be asked to read a text and give feedback afterwards
|
Experimental: Narrative Text
The narrative text contains the same information as the non-narrative text, except that it is built into a story.
This makes the text slightly longer at 725 words.
The text is about a main character and two work colleagues who share their personal experiences about nutrition and exercise.
|
Participants will be asked to read a text and give feedback afterwards
|
Experimental: Non-Narrative Animation
The animation with a total duration of 3:12 min is based on the text in non-narrative form and aims to be as fully comparable as possible.
|
Participants will be asked to watch a video and give feedback afterwards
|
Experimental: Narrative Animation
The animaion (3:45 min) is based on the text in narrative form and aims to be as fully comparable as possible.
|
Participants will be asked to watch a video and give feedback afterwards
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction with the materials
Time Frame: 20 minutes
|
Participants will be asked questions regarding the material presented (qualitatively and quantitatively) covering general satisfaction, comprehensibility, persuasion, affective reactions and potential ways to improve the material. The quantitative items regarding general satisfaction and counter-argumentation are rated on a 5-point Likert scale ranging from 1 = "Do not agree at all" to 5 = "Fully agree" with higher scores indicating higher satisfaction with the material as well as higher counter-argumentation. Identification with characters will be measured using one item asking "What was the extent to which you could identify with the main characters in the animation?". Participants in the narrative condition will rate this question per character on a scale of 1 (very low) to 10 (very high), so higher scores indicate higher identification. |
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cancer Prevention Beliefs & Cancer Information Overload
Time Frame: 5 minutes
|
Participans will be assessed asking for agreement with three statements that have been used in previous studies: "It seems like everything causes cancer," "There's not much you can do to lower your chances of getting cancer," and "There are so many recommendations about preventing cancer, it's hard to know which ones to follow".
Participants will indicate agreement on a 4-point likert scale ranging from 1 = "strongly agree" to 4 = "strongly disagree".
|
5 minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Karen Steindorf, Prof. Dr., German Cancer Research Center
- Principal Investigator: Alexander Haussmann, Dr., German Cancer Research Center
- Principal Investigator: Florian Herbolsheimer, Dr., German Cancer Research Center
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CLARO Pilot
- 70114759 (Other Grant/Funding Number: German Cancer Aid)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Prevention
-
M.D. Anderson Cancer CenterActive, not recruitingCancer PreventionUnited States
-
IWK Health CentreLaval University; Canadian Association of Fire ChiefsRecruiting
-
AshtaYoga, LLCColumbia University; University Of Nigeria Teaching Hospital; Project PINKBLUE... and other collaboratorsNot yet recruitingStep up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among NigeriansCancer PreventionNigeria
-
HealthPartners InstituteCompleted
-
Case Comprehensive Cancer CenterActive, not recruiting
-
AshtaYoga, LLCColumbia University; University Of Nigeria Teaching Hospital; Project PINKBLUE... and other collaboratorsCompletedCancer PreventionNigeria
-
M.D. Anderson Cancer CenterWithdrawnCancer | Prevention Harmful Effects
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedTobacco Use Cessation | Cancer PreventionUnited States
-
University of California, DavisRecruitingCancer Awareness and Prevention EducationUnited States
-
University of British ColumbiaCanadian Cancer Society (CCS)Completed
Clinical Trials on text in non-narrative form
-
University of GlasgowCompletedCancer ScreeningUnited Kingdom
-
Purdue UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Zhu DianActive, not recruitingMedication Adherence | Schizophrenia and Related Disorders | Gamification | Mental Health IssueChina
-
Poitiers University HospitalRecruitingArthritis | Oncology | Adverse Drug Event | AutoimmunityFrance
-
University of Arkansas, FayettevilleNational Cancer Institute (NCI); University of California, Los Angeles; Thomas... and other collaboratorsActive, not recruitingVaccine-Preventable Diseases | Human Papilloma VirusUnited States
-
Children's Hospital of PhiladelphiaNational Institute of Neurological Disorders and Stroke (NINDS); North American...RecruitingMitochondrial Diseases | Mitochondrial Myopathies | MELAS | Mitochondrial Encephalomyopathies | MERRFUnited States
-
Colorado State UniversityInstitute of Cannabis ResearchCompleted
-
Centre for Addiction and Mental HealthCompletedPsychotic DisordersCanada
-
Rennes University HospitalTerminated
-
TaiwanJ Pharmaceuticals Co., LtdUnknownAutoimmune Hepatitis